Stock Rise Follows I-Flow Device Approval
Bloomberg News
I-Flow Corp.’s stock rose $1.66 a share, or 41%, to $5.69 a share after the Lake Forest maker of infusion systems said the U.S. Food and Drug Administration will allow the company to market its new catheter for pain management of large surgical incisions.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
